Search results
Lupus Complications Reduced With Common Diabetes Drug
MedPage Today· 3 days agoPeople with systemic lupus erythematosus (SLE) had lower rates of lupus nephritis, chronic kidney disease, and other complications when they were taking ...
'Unprecedented' CAR-T results for lupus net Insight prize for researchers
FierceBiotech· 2 days agoTwo scientists whose work sparked industry excitement about the prospect of using chimeric antigen...
US FDA approves Roche's drug for a chronic blood disorder
Reuters via Yahoo News· 2 days agoThe drug crovalimab, branded as PiaSky, is a monthly under-the-skin or intravenous treatment for...
CAR-T therapy achieves lupus remission breakthrough
BioPharma-Reporter· 5 days agoThis is the first trial to date to show safe elimination of all autoantibodies in patients with systemic lupus erythematosus (SLE) and lupus nephritis (...
Is Adicet Bio, Inc. (NASDAQ:ACET) the Best Halal Stock ?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled the list of the 7 Best Halal Stocks To Buy Now (Debt Free) according to the...
Kyverna's CAR-T relapse in lupus dents autoimmune hopes amid biotech gold rush
FierceBiotech· 6 days agoThe “remarkable” success of chimeric antigen receptor T-cell therapy (CAR-T) in lupus has led to a...
Multiscale topology classifies cells in subcellular spatial transcriptomics - Nature
Nature· 4 days agoA method for topological automatic cell type classification across subcellular resolution spatial transcriptomic platforms is proposed, resolving cell type information and locating sparsely dispersed cells in human kidney and mouse kidney and brain.
Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?
Zacks via Yahoo Finance· 6 days agoAurinia (AUPH) saw its shares surge in the last session with trading volume being higher than...
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome...
Tehachapi News· 6 days agoKyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced ...
Q32 Bio (NASDAQ:QTTB) Receives New Coverage from Analysts at Guggenheim
ETF DAILY NEWS· 5 days agoGuggenheim assumed coverage on shares of Q32 Bio (NASDAQ:QTTB – Free Report) in a research report released on Monday, Marketbeat reports. The firm issued a buy rating and a $100.00 target price ...